Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients

Figure 4 ∆ alanine aminotransferase decline and %∆alanine aminotransferase decline by baseline alanine aminotransferase level (≥ 40 U/L and < 40 U/L). ∆ALT decline is defined as the ALT level at 24 wk after end of treatment subtracted from baseline. %∆ALT decline is defined as the percentage of ALT at 24 wk after end of treatment subtracted from baseline. The vertical bars represent the standard errors of the mean. Dual therapy: Pegylated-interferon-α and ribavirin; Triple therapy: Telaprevir-based therapy combined with pegylated-interferon-α and ribavirin; ALT: Alanine aminotransferase.